
Merck Unveils Strategic Transformation Plan with $3 Billion Cost Optimization Initiative
11 September 2025Strategic Transformation at Merck Merck has announced a significant $3 billion cost-cutting initiative to be implemented by the end of 2027, with plans to reinvest these savings into new product launches and its drug pipeline. This strategic move comes as the company prepares for the upcoming patent expiration of its blockbuster cancer drug Keytruda in […]